Navigation Links
Spherix Releases Update Letter to Shareholders

BETHESDA, Md., March 7, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, released a letter to shareholders. The text of the letter is below:

To My Fellow Shareholders:

We enter 2016 with increased optimism, after a challenging, yet ultimately productive, 2015. We took significant steps and achieved meaningful milestones last year.  We now have the opportunity to diversify business and position Spherix for success in 2016. I am excited to share our vision and objectives for 2016 and beyond. 

Over the past several years, the patent monetization industry has evolved.  There has been rising resistance by potential patent licensees to resolve patent disputes in a fair and reasonable manner.  In our assessment, many potential licensees would rather wait to see if a company will fail, rather than reach a fair and reasonable settlement on technology they are using without adequate remuneration. 

This approach by potential licensees to request for fair and reasonable licenses is disappointing.  However, as the patent monetization space evolves, we will evolve with it.  This year, we intend to partner with much larger patent monetization organizations that have the financial resources to maximize our assets.  Our goal is to drive long-term shareholder value through partnerships that will initiate litigation across numerous technology sectors, including: routers, switching, networking, optical, and internet service.  Multiple litigations, against multiple licensees, in multiple technology fields will help to optimize potential revenue generation.  With an expansive addressable market we believe to be more than $50 billion, our strategy should position us to pursue and capture licensing revenue from a broad spectrum of technology companies that today utilize technologies protected by our patents.

This strategy is now available to Spherix, as a result of the satisfaction of our preferred stock payment obligations and the termination of all security interests on our assets.  Prior to the end of 2015, we did not have the right to leverage our portfolio in such a manner.  Our focus during the last few months has been on resolving this challenge, and I am pleased to report that we have completed this initiative.

Our strategy is well positioned in light of what appears to be the end of proposed patent reform legislation for 2016.  As noted in the February 23, 2016, Washington Times article by Kellan Howell, patent reform legislation proposed by Rep. Bob Goodlatte of Virginia is stalled and unlikely to reach the Senate or President Obama's desk this year, according to the author.  The removal of this cloud on the sector and the ability to diversify revenue, should position us for a strong 2016.

Another milestone for 2016 includes the continued discussions with RPX, as are required under the partial license sold to RPX in November of 2015.  Spherix is committed to continuing those discussions in good faith and we hope to reach a fair and reasonable license.  By agreement, these discussions can continue until May 23rd of this year.  If an agreement is not reached by May 23rd, then the agreed "stay" on litigation expires and the number of potential licensees to our portfolio increases significantly.

Our goal is to create long term value for our shareholders.  This value will be a direct result of our ability to derive revenue from the assets we acquired from Rockstar and others.  Our new partnership approach will help drive revenue and cash flow by increasing potential licensing opportunities, while simultaneously decreasing our cash outlays. 

The times have changed for our market sector and it is important for shareholders to know that we are aware of these changes and are pivoting to change with them.  Prior to the vote on our recent reverse split, I spoke to many shareholders and listened to your comments and concerns.  I have taken your feedback seriously.  Spherix is well positioned for a successful 2016 and I hope this letter provides clearer guidance on the road ahead.

I thank you for being a Spherix shareholder.


Anthony Hayes
Chief Executive Officer

About Spherix
Spherix Incorporated was launched in 1967 as a scientific research company. Spherix is committed to advancing innovation by active participation in the patent market. Spherix draws on portfolios of pioneering technology patents to partner with and support product innovation.

Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

 Contact:Investor Relations:

Hayden IRBrett Mass, Managing PartnerPhone: (646) 536-7331Email: www.haydenir.comSpherix:

Phone: (703) 992-9325Email:

Logo -

SOURCE Spherix Incorporated
Copyright©2016 PR Newswire.
All rights reserved

Related biology technology :

1. General Patent Corporation Chairman and CEO Alexander Poltorak Joins Spherix Board Industry veteran and authority on patent law and valuation joins Spherix as director
2. Spherix Announces Private Placement as the Company Continues to Execute its Patent Monetization Program - Spherix accepts $2.0 Million from Investors
3. Spherix Announces Additions to Technology Advisory Board in Areas of Licensing and Litigation Support
4. Spherix Announces the Closing of Private Placement of $2,235,000
5. Spherix Announces Settlement Agreement and Continued Monetization of Patent Portfolio
6. Spherixs Wholly Owned Subsidiary Sues AT&T Inc. and AT&T Mobility for Infringement of Patent for Geolocation of Cell Phones in Second Cell Phone Location Suit for Spherix
7. Spherix CEO, Anthony Hayes Appears on Bloombergs "Taking Stock With Pimm Fox"
8. Spherix Appoints Richard Cohen as Chief Financial Officer
9. Spherix Secures License For CompuFill Patents - Agreement Represents Spherix Second License Agreement Under New License Campaign
10. Spherix Schedules Shareholder Update Call
11. United States Patent & Trademark Office Issues Three New Standard Essential Patents to Spherix
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... They ... a complex biological network, a depiction of a system of linkages and connections ... Korkin, PhD, associate professor of computer science at Worcester Polytechnic Institute (WPI) and ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces ... addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market ... hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at . 2016 Year ...
(Date:4/13/2017)... April 13, 2017 According to a new market ... Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, ... Market is expected to grow from USD 14.30 Billion in 2017 to ... of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Biology News(10 mins):